McFarlane Neil F. sold ZVRA
February 2, 2026 · Form 4 insider transaction
McFarlane Neil F. sold 91,000 shares of Zevra Therapeutics, Inc. at $9.38 per share, a transaction worth $853.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
91,000
Price
$9.38
Total value
$853.4K
InsiderMcFarlane Neil F.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 2, 2026
Shares owned after364,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Adoption date of referenced 10b5-1(c) plan is: 03-21-2025.; This transaction was executed in multiple trades at prices ranging from $8.94 to $9.53. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.